Brainstorm cell therapeutics inc. reports earnings results for the third quarter ended september 30, 2019

Brainstorm cell therapeutics inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 5.551 million compared to usd 3.232 million a year ago. net loss was usd 5.634 million compared to usd 3.176 million a year ago. basic loss per share from continuing operations was usd 0.25 compared to usd 0.15 a year ago. for the nine months, operating loss was usd 15.336 million compared to usd 8.626 million a year ago. net loss was usd 15.561 million compared to usd 8.565 million a year ago. basic loss per share from continuing operations was usd 0.72 compared to usd 0.43 a year ago.
BCLI Ratings Summary
BCLI Quant Ranking